Medidata Solutions Inc (MDSO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Medidata Solutions Inc (MDSO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10108
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data and analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analytics solutions, using secure cloud and hybrid cloud infrastructure. Medidata’s service portfolio includes implementation, configuration, data testing, and integration support, training, reporting and consultation services for clinical development process. Medidata offers its services to pharmaceutical, biotechnology and medical device companies, academic institutions, and contract research organizations (CROs). The company markets and sells its products through direct sales force, CROs and strategic partners in North America, Europe and Asia. Medidata is headquartered in New York, the US.

Medidata Solutions Inc (MDSO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Medidata Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Medidata Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 10
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Medidata Solutions and Decibel Therapeutics Enter into Agreement 12
Akros Pharma Enters into Agreement with Medidata 13
Auris Medical Enters Into Agreement With Medidata Solutions 14
Acquisition 15
Medidata Solutions Acquired Mytrus 15
Medidata Solutions Inc – Key Competitors 16
Medidata Solutions Inc – Key Employees 17
Medidata Solutions Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Strategy And Business Planning 20
Sep 27, 2017: Medidata Opens New, Larger London EMEA Headquarters 20
Financial Announcements 21
Oct 18, 2018: Medidata announces third quarter 2018 results 21
Jul 24, 2018: Medidata Reports Second Quarter 2018 Results 22
Apr 19, 2018: Medidata Announces First Quarter 2018 Results 23
Feb 08, 2018: Medidata Reports Record Full-Year and Fourth Quarter 2017 Results 24
Oct 26, 2017: Medidata Reports Record Third Quarter 2017 Results 26
Jul 18, 2017: Medidata Reports Record Second Quarter 2017 Results 28
Apr 26, 2017: Medidata Reports Record First Quarter 2017 Results 30
Feb 09, 2017: Medidata Reports Record Full-Year and Fourth Quarter 2016 Results 32
Corporate Communications 34
Oct 23, 2018: Medidata Sets Major New Corporate Social Responsibility (CSR) Commitments 34
Oct 22, 2018: Medidata Appoints Dr.Maria Rivas to its Board of Directors 35
Legal and Regulatory 36
May 08, 2018: Medidata Offers Breakthrough to De-Risk Clinical Trial Submissions 36
Government and Public Interest 37
Jul 26, 2018: Medidata corporate social responsibility initiatives benefit patients, students, and communities 37
Mar 28, 2018: Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives 38
Product News 39
Jun 25, 2018: Clinical Research Can Now Be Truly Patient-Centric By Quantifying Patient Burden with Medidata 39
Other Significant Developments 40
Feb 20, 2018: Santen Pharmaceutical to Leverage Medidata Edge CTMS to Drive Future Growth in Ophthalmic Clinical Development 40
Feb 13, 2018: Medidata Introduces New Edge Family of Products for Clinical Operations at SCOPE 2018 41
Jul 20, 2017: “Nature Reviews Drug Discovery” Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Medidata Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Medidata Solutions Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Medidata Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 10
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Medidata Solutions and Decibel Therapeutics Enter into Agreement 12
Akros Pharma Enters into Agreement with Medidata 13
Auris Medical Enters Into Agreement With Medidata Solutions 14
Medidata Solutions Acquired Mytrus 15
Medidata Solutions Inc, Key Competitors 16
Medidata Solutions Inc, Key Employees 17
Medidata Solutions Inc, Other Locations 18
Medidata Solutions Inc, Subsidiaries 19

List of Figures
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Medidata Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Medidata Solutions Inc (MDSO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Intel Corporation:企業のM&A・事業提携・投資動向
    Intel Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intel Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Green Energy Options Ltd:企業の戦略的SWOT分析
    Green Energy Options Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • SteadyMed Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary SteadyMed Therapeutics Inc (SteadyMed), a subsidiary of SteadyMed Ltd is a pharmaceutical company that develops and commercializes therapeutic product candidates. The company provides patchpump, a customizable, pre-filled, and pre-programmed disposable parenteral delivery platform for large …
  • Southern California Edison Co:企業の発電所・SWOT分析2018
    Southern California Edison Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Crocs Inc (CROX):企業の財務・戦略的SWOT分析
    Crocs Inc (CROX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • China Eastern Airlines Corporation Limited:企業の戦略・SWOT・財務分析
    China Eastern Airlines Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Eastern Airlines Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Nippon Light Metal Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Nippon Light Metal Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Light Metal Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • CNOOC Limited:企業の戦略・SWOT・財務分析
    CNOOC Limited - Strategy, SWOT and Corporate Finance Report Summary CNOOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Huishang Bank Corp Ltd:企業の戦略・SWOT・財務分析
    Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MAB Discovery GmbH-製薬・医療分野:企業M&A・提携分析
    Summary MAB Discovery GmbH (MAB Discovery) is a drug discovery and development company that offers novel antibody therapeutics. The company produces monoclonal antibodies derived from rabbits and rats. It relies on natural immune response and state of the art B cell cloning techniques for the produc …
  • Westinghouse Electric Co LLC:企業の戦略的SWOT分析
    Westinghouse Electric Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Furukawa Electric Co Ltd (FUWAY):企業の財務・戦略的SWOT分析
    Furukawa Electric Co Ltd (FUWAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Dynavax Technologies Corp (DVAX):製薬・医療:M&Aディール及び事業提携情報
    Summary Dynavax Technologies Corp (Dynavax), formerly Double Helix Corp, is a clinical-stage biopharmaceutical company that develops product candidates for the prevention of infectious and inflammatory disease. The company’s only marketed product Heplisav-B is an adult vaccine for hepatitis B. Its p …
  • Nihon Medi-Physics Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Nihon Medi-Physics Co Ltd (NMCL), a subsidiary of Sumitomo Chemical Co Ltd, is a radioactive pharmaceuticals and radioactive medical device manufacturer. The company offers research, development, production, sale, purchase and import and export of radioactive pharmaceuticals, medical devices …
  • Ibersol S.G.P.S., S.A.:企業の戦略・SWOT・財務分析
    Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report Summary Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PerkinElmer Inc (PKI):企業の財務・戦略的SWOT分析
    PerkinElmer Inc (PKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Capcom Co. Ltd. (9697):企業の財務・戦略的SWOT分析
    Capcom Co. Ltd. (9697) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Buckeye Partners, L.P.:企業の戦略・SWOT・財務分析
    Buckeye Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Buckeye Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • DowDuPont Inc (DWDP):企業の財務・戦略的SWOT分析
    DowDuPont Inc (DWDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆